{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:56:19Z","timestamp":1782248179857,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jconrel.2024.03.043","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:55:31Z","timestamp":1711634131000},"page":"199-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["M-MDSCs mediated trans-BBB drug delivery for suppression of glioblastoma recurrence post-standard treatment"],"prefix":"10.1016","volume":"369","author":[{"given":"Tong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2024.03.043_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clineuro.2012.04.005","article-title":"The influence of surgery on recurrence pattern of glioblastoma","volume":"115","author":"De Bonis","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.jconrel.2024.03.043_bb0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3171\/2012.7.JNS12147","article-title":"Prognosis of patients with multifocal glioblastoma: a case-control study clinical article","volume":"117","author":"Patil","year":"2012","journal-title":"J. Neurosurg."},{"issue":"10","key":"10.1016\/j.jconrel.2024.03.043_bb0015","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1021\/nn402662d","article-title":"Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier","volume":"7","author":"Miura","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.03.043_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2377-9-S1-S3","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.03.043_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/2326-6066.CIR-15-0151","article-title":"Glioblastoma eradication following immune checkpoint blockade in an orthotopic, immunocompetent model","volume":"4","author":"Reardon","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2024.03.043_bb0030","series-title":"Annual Review of Pathology: Mechanisms of Disease","first-page":"323","article-title":"Mechanisms of leukocyte Transendothelial migration","volume":"Vol. 6","author":"Muller","year":"2011"},{"issue":"12","key":"10.1016\/j.jconrel.2024.03.043_bb0035","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","article-title":"Capture, crawl, cross: the T cell code to breach the blood-brain barriers","volume":"33","author":"Engelhardt","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2024.03.043_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fimmu.2019.01078","article-title":"Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment","volume":"10","author":"Harjunpaa","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2024.03.043_bb0045","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1172\/JCI44952","article-title":"IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells","volume":"121","author":"Fisher","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2024.03.043_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/jsre.1995.1133","article-title":"Enhanced expression of ICAM-1 in a murine fibrosarcoma reduces tumor-growth rate","volume":"59","author":"Sartor","year":"1995","journal-title":"J. Surg. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2024.03.043_bb0055","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1053\/j.gastro.2009.10.057","article-title":"Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer","volume":"138","author":"Mlecnik","year":"2010","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.jconrel.2024.03.043_bb0060","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/jid.2013.36","article-title":"Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma","volume":"133","author":"Afanasiev","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.jconrel.2024.03.043_bb0065","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1084\/jem.20071190","article-title":"Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells","volume":"205","author":"Clark","year":"2008","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.jconrel.2024.03.043_bb0070","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1158\/1078-0432.CCR-06-2450","article-title":"T-cell distribution and adhesion receptor expression in metastatic melanoma","volume":"13","author":"Weishaupt","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.jconrel.2024.03.043_bb0075","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","article-title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter","volume":"24","author":"Lim","year":"2022","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.jconrel.2024.03.043_bb0080","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1470-2045(14)70189-5","article-title":"Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial","volume":"15","author":"Kwon","year":"2014","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.03.043_bb0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00262-016-1953-z","article-title":"Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients","volume":"66","author":"Jordan","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.jconrel.2024.03.043_bb0090","first-page":"796","article-title":"Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1\/PD-L1 mechanism in glioblastoma","volume":"19","author":"Antonios","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"5","key":"10.1016\/j.jconrel.2024.03.043_bb0095","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1 alpha., and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2024.03.043_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.biomaterials.2017.07.007","article-title":"Liver specific gene immunotherapies resolve immune suppressive ectopic lymphoid structures of liver metastases and prolong survival","volume":"141","author":"Goodwin","year":"2017","journal-title":"Biomaterials"},{"issue":"41","key":"10.1016\/j.jconrel.2024.03.043_bb0105","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1021\/bi400716w","article-title":"Tribody: robust self-assembled trimeric targeting ligands with high stability and significantly improved target-binding strength","volume":"52","author":"Kim","year":"2013","journal-title":"Biochemistry"},{"issue":"5966","key":"10.1016\/j.jconrel.2024.03.043_bb0110","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jconrel.2024.03.043_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.128.3.415","article-title":"Origin and kinetics of mononuclear phagocytes","volume":"128","author":"Vanfurth","year":"1968","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.jconrel.2024.03.043_bb0120","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1158\/1078-0432.CCR-10-2557","article-title":"Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-beta","volume":"17","author":"Lohr","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2024.03.043_bb0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneuroim.2010.05.020","article-title":"Prognostic significance and mechanism of Treg infiltration in human brain tumors","volume":"225","author":"Jacobs","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"23","key":"10.1016\/j.jconrel.2024.03.043_bb0130","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"J. Am. Med. Assoc."},{"issue":"23","key":"10.1016\/j.jconrel.2024.03.043_bb0135","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma a randomized clinical trial","volume":"314","author":"Stupp","year":"2015","journal-title":"J. Am. Med. Assoc."},{"issue":"11","key":"10.1016\/j.jconrel.2024.03.043_bb0140","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.4161\/cbt.7.11.7156","article-title":"Nanosize delivery as an emerging platform for cancer therapy commentary","volume":"7","author":"Li","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jconrel.2024.03.043_bb0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jconrel.2016.03.031","article-title":"Nanobiotechnology-based delivery strategies: new frontiers in brain tumor targeted therapies","volume":"240","author":"Mangraviti","year":"2016","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2024.03.043_bb0150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.mattod.2015.11.025","article-title":"Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery","volume":"19","author":"Mo","year":"2016","journal-title":"Mater. Today"},{"issue":"2","key":"10.1016\/j.jconrel.2024.03.043_bb0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2005.09.053","article-title":"Barriers to carrier mediated drug and gene delivery to brain tumors","volume":"110","author":"Huynh","year":"2006","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2024.03.043_bb0160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.03.043_bb0165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/17425247.2011.559457","article-title":"Cell-mediated drug delivery","volume":"8","author":"Batrakova","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2024.03.043_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrc.2015.3","article-title":"Biomaterials and emerging anticancer therapeutics: engineering the microenvironment","volume":"16","author":"Gu","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.jconrel.2024.03.043_bb0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.addr.2007.08.029","article-title":"Cell-based drug delivery","volume":"60","author":"Pierige","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2024.03.043_bb0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.jconrel.2024.03.043_bb0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2024.03.043_bb0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2024.03.043_bb0195","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.jconrel.2024.03.043_bb0200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3322","article-title":"Paths to stemness: building the ultimate antitumour T cell","volume":"12","author":"Gattinoni","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.jconrel.2024.03.043_bb0205","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2326-6066.CIR-17-0405","article-title":"Reducing ex vivo culture improves the antileukemic activity of chimeric antigen receptor (CAR) T cells","volume":"6","author":"Ghassemi","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2024.03.043_bb0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI85631","article-title":"Selection bias: maintaining less-differentiated T cells fore adoptive immunotherapy","volume":"126","author":"Xu","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.jconrel.2024.03.043_bb0215","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1158\/1078-0432.CCR-09-3087","article-title":"Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy","volume":"16","author":"Alizadeh","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2024.03.043_bb0220","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.jconrel.2024.03.043_bb0225","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1089\/neu.2011.1860","article-title":"Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury","volume":"28","author":"Lee","year":"2011","journal-title":"J. Neurotrauma"},{"issue":"6","key":"10.1016\/j.jconrel.2024.03.043_bb0230","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","article-title":"CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNF alpha","volume":"11","author":"Ren","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.jconrel.2024.03.043_bb0235","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1021\/acsnano.7b01786","article-title":"Transient and local expression of chemokine and immune checkpoint traps to treat pancreatic cancer","volume":"11","author":"Miao","year":"2017","journal-title":"ACS Nano"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T01:56:33Z","timestamp":1728525393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924001962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":47,"alternative-id":["S0168365924001962"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M-MDSCs mediated trans-BBB drug delivery for suppression of glioblastoma recurrence post-standard treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}